liquid biopsy

Combining cell-free RNA with cell-free DNA in liquid biopsy forhematologic and solid tumors
Publications

Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors

Introducing a novel liquid biopsy approach combining cfRNA and cfDNA sequencing. Our findings demonstrate superior mutation detection with cfRNA, while cfDNA excels in identifying chromosomal aberrations. Elevated cfRNA biomarkers correlate with tumor types, aiding diagnosis. Machine learning predicts cancer types accurately. Host immune response analysis through cfRNA ratios reveals distinct patterns in cancer patients. This integrated approach holds promise for predicting genomic abnormalities and cancer diagnosis

Read More »
cancer-cell tumor-informed vs tumor-naive
Article

Τumor-informed vs Tumor-naïve

Liquid biopsies are a rapidly evolving diagnostic technology with numerous labs offering commercially available tests today. Most labs have taken an approach of cell-free (cfDNA)

Read More »
ASH22 Posters
Genomics

ASH22 Posters

GTC presented abstracts at ASH 2022 GTC’s posters from 2022 Convention of American Society of Hematology are now available to be downloaded. Please reach out

Read More »
GTC posters at ASH 2021 - Atlanta GA
Genomics

ASH21 Posters

In partnership with Anthology Diagnostics and Key Genomics, GTC presented four abstracts at ASH 2021 GTC’s posters from 2021 Convention of American Society of Hematology

Read More »